Filing Flows › Comparisons › MDLN vs SYK
Medline vs Stryker: MDLN and SYK compared
Medline is the larger company: $7.9B of revenue in its latest quarter (Q3 2026) against $6.5B for Stryker (Q3 2026). Medline is growing faster (+10% against +8% a year earlier). Stryker is more profitable, with an operating margin of 15.9% against 6.4%.
Where the money goes: MDLN and SYK
Medline (MDLN) · Q3 2026
Medline, Q3 2026: revenue $7.9B (+10% year over year), operating margin 6.4%, net earnings $198M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Stryker (SYK) · Q3 2026
Stryker, Q3 2026: revenue $6.5B (+8% year over year), operating margin 15.9%, net earnings $753M, operating cash flow $1.5B. The chart follows the revenue to costs, profit and cash.
| Medline (MDLN) | Stryker (SYK) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $7.9B | $6.5B |
| Revenue growth, Y/Y | +10% | +8% |
| Gross margin | 24.5% | 65.2% |
| Operating margin | 6.4% | 15.9% |
| Net earnings | $198M | $753M |
| Net margin | 2.5% | 11.5% |
| Operating cash flow | $1.0B | $1.5B |
| Free cash flow | $884M | $1.2B |
| Market value | $52.3B | $128.9B |
| P/E | 59.7× | 35.7× |
| Analysts’ mean target | $44.81 | $340.48 |
Where the revenue comes from
Stryker
- MedSurg and Neurotechnology:: $3.7B (56%)
- Orthopaedics:: $2.9B (44%)
Questions
Which is bigger, Medline or Stryker?
Medline is the larger company: $7.9B of revenue in its latest quarter (Q3 2026) against $6.5B for Stryker (Q3 2026).
Is Medline or Stryker growing faster?
Medline is growing faster (+10% against +8% a year earlier).
Which is more profitable, Medline or Stryker?
Stryker is more profitable, with an operating margin of 15.9% against 6.4%.
More: Medline earnings · how Medline makes money · Stryker earnings · how Stryker makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 30, 2026). Fiscal quarters can end on different dates. Not investment advice.